CAR T Cell Therapy Achieves Breakthrough in Multiple Myeloma Trials
Researchers at the University of Texas MD Anderson Cancer Center have reported promising results for the chimeric antigen receptor (CAR) T cell therapy known as anitocabtagene autoleucel (anito-cel) in the…